Igor D. Marques-Bacelar

Sao Luis, MA, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Epidemiology of glomerular diseases in Northeastern Brazil from 2008-2024.

Epidemiology of glomerular diseases in Northeastern Brazil from 2008-2024.

Journal: Jornal brasileiro de nefrologia

Published: October 27, 2025

EPI-CKD Brazil: point-of-care screening for chronic kidney disease during World Kidney Day.

EPI-CKD Brazil: point-of-care screening for chronic kidney disease during World Kidney Day.

Journal: Jornal brasileiro de nefrologia

Published: October 01, 2025

Collapsing Glomerulopathy in Brazil: A Nationwide Descriptive Study.

Collapsing Glomerulopathy in Brazil: A Nationwide Descriptive Study.

Journal: Nephrology (Carlton, Vic.)

Published: April 06, 2025

Minimal Change Disease and Focal Segmental Glomerulosclerosis Are Associated with Good Kidney Prognosis and Thrombotic Microangiopathy with Poor Kidney Survival in Patients with COVID-19-Associated Nephropathies.

Minimal Change Disease and Focal Segmental Glomerulosclerosis Are Associated with Good Kidney Prognosis and Thrombotic Microangiopathy with Poor Kidney Survival in Patients with COVID-19-Associated Nephropathies.

Journal: American journal of nephrology

Published: October 17, 2024

Brazilian Consortium for the Study on Renal Diseases Associated With COVID-19: A Multicentric Effort to Understand SARS-CoV-2-Related Nephropathy.

Brazilian Consortium for the Study on Renal Diseases Associated With COVID-19: A Multicentric Effort to Understand SARS-CoV-2-Related Nephropathy.

Journal: Frontiers in medicine

Published: July 16, 2020

Authors' Reply.

Authors' Reply.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 27, 2019

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 25, 2018

Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.

Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.

Journal: International urology and nephrology

Published: April 14, 2014

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease.

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease.

Journal: Kidney international

Published: February 18, 2014

Vasculopathy in the kidney allograft at time of transplantation delays recovery of graft function after deceased-donor kidney transplantation

Vasculopathy in the kidney allograft at time of transplantation delays recovery of graft function after deceased-donor kidney transplantation

Journal: Jornal brasileiro de nefrologia

Published: October 24, 2013

Rejection-triggered haemophagocytic syndrome in renal transplantation successfully treated with intravenous immunoglobulin.

Rejection-triggered haemophagocytic syndrome in renal transplantation successfully treated with intravenous immunoglobulin.

Journal: Clinical kidney journal

Published: March 08, 2013

Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade.

Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade.

Journal: Clinical transplantation

Published: November 20, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026